Cargando…
干扰素α-1b、白细胞介素2联合沙利度胺方案干预治疗微小残留病阳性急性髓系白血病的疗效分析
OBJECTIVE: To explore the effect of combination regimen of interferon alpha-1b, interleukin-2 and thalidomide (ITI regimen) on minimal residual disease (MRD) in patients with acute myeloid leukemia (AML) who were in hematologic remission but MRD-positive. METHODS: Eighteen patients (17 from Tumor Ho...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342653/ https://www.ncbi.nlm.nih.gov/pubmed/30831625 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.02.004 |
Ejemplares similares
-
干扰素α-1b、白细胞介素-2联合沙利度胺方案维持治疗急性髓系白血病的临床观察
Publicado: (2020) -
沙利度胺联合干扰素对Kasumi-1细胞的增殖抑制作用及其机制研究
Publicado: (2015) -
CAG预激方案联合沙利度胺、干扰素、重组人IL-2治疗难治复发性急性髓系白血病疗效分析
Publicado: (2016) -
白细胞介素-1与肿瘤
Publicado: (2010) -
干扰素联合白细胞介素2治疗异基因造血干细胞移植术后高危及微小残留病升高患者疗效及安全性观察
Publicado: (2019)